CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chf Scientific Operations Off gave up 4,653 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 5,069 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 50,000 shares at $16.00 ($800,000)
- 4 Open-market buy 10% owner bought 300,000 shares at $16.87 ($5,061,000)
- 4 Open-market buy Chief Financial Officer bought 1,481 shares at $16.91 ($25,038)
- 4 Open-market sale Former 10% Owner sold 2,554 shares at an average $19.40 ($49,541)
- 4 Open-market sale 10% owner sold 239 shares at $18.00 ($4,302)
- 4 Open-market sale 10% owner sold 13,330 shares at an average $18.73 ($249,632)
- 4 Open-market sale 10% owner sold 259 shares at an average $20.58 ($5,331)
- 4 Open-market sale 10% owner sold 771 shares at $22.09 ($17,031)
- 4 Open-market sale 10% owner sold 2,034 shares at an average $22.39 ($45,543)
- 4 Open-market sale 10% owner sold 3,435 shares at an average $22.85 ($78,496)
- 4 Open-market sale 10% owner sold 510 shares at $24.18 ($12,333)
Page 9 of 20 · 382 filings